- Home
- BCTX vs FLYE Comparison
BCTX vs FLYE Comparison
Compare BCTX & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- FLYE
- Stock Information
- Founded
- BCTX 2014
- FLYE 2018
- Country
- BCTX Canada
- FLYE United States
- Employees
- BCTX N/A
- FLYE N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- FLYE Aerospace
- Sector
- BCTX Health Care
- FLYE Industrials
- Exchange
- BCTX Nasdaq
- FLYE Nasdaq
- Market Cap
- BCTX 17.2M
- FLYE 10.7M
- IPO Year
- BCTX N/A
- FLYE 2024
- Fundamental
- Price
- BCTX $0.73
- FLYE $0.45
- Analyst Decision
- BCTX Strong Buy
- FLYE
- Analyst Count
- BCTX 1
- FLYE 0
- Target Price
- BCTX $15.00
- FLYE N/A
- AVG Volume (30 Days)
- BCTX 760.8K
- FLYE 323.3K
- Earning Date
- BCTX 12-12-2024
- FLYE 11-19-2024
- Dividend Yield
- BCTX N/A
- FLYE N/A
- EPS Growth
- BCTX N/A
- FLYE N/A
- EPS
- BCTX N/A
- FLYE N/A
- Revenue
- BCTX N/A
- FLYE $30,297,313.00
- Revenue This Year
- BCTX N/A
- FLYE N/A
- Revenue Next Year
- BCTX N/A
- FLYE N/A
- P/E Ratio
- BCTX N/A
- FLYE N/A
- Revenue Growth
- BCTX N/A
- FLYE 14.77
- 52 Week Low
- BCTX $0.46
- FLYE $0.43
- 52 Week High
- BCTX $5.97
- FLYE $7.62
- Technical
- Relative Strength Index (RSI)
- BCTX 50.47
- FLYE N/A
- Support Level
- BCTX $0.57
- FLYE N/A
- Resistance Level
- BCTX $0.82
- FLYE N/A
- Average True Range (ATR)
- BCTX 0.07
- FLYE 0.00
- MACD
- BCTX 0.01
- FLYE 0.00
- Stochastic Oscillator
- BCTX 65.27
- FLYE 0.00
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.